Ralston SH - Search Results

1

Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorption.

Greig IR, Idris AI, Ralston SH, van't Hof RJ. Greig IR, et al. Among authors: ralston sh. J Med Chem. 2006 Dec 14;49(25):7487-92. doi: 10.1021/jm051236m. J Med Chem. 2006. PMID: 17149877

2

Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors.

Van 't Hof RJ, Idris AI, Ridge SA, Dunford J, Greig IR, Ralston SH. Van 't Hof RJ, et al. Among authors: ralston sh. J Bone Miner Res. 2004 Oct;19(10):1651-60. doi: 10.1359/jbmr.2004.19.10.1651. J Bone Miner Res. 2004. PMID: 15355560 Free article.

3

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.

Idris AI, van 't Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH. Idris AI, et al. Among authors: ralston sh. Nat Med. 2005 Jul;11(7):774-9. doi: 10.1038/nm1255. Epub 2005 May 22. Nat Med. 2005. PMID: 15908955 Free PMC article.

4

Discovery of biphenylketones as dual modulators of inflammation and bone loss.

Greig IR, Coste E, Ralston SH, van't Hof RJ. Greig IR, et al. Among authors: ralston sh. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5548-51. doi: 10.1016/j.bmcl.2010.07.055. Epub 2010 Jul 18. Bioorg Med Chem Lett. 2010. PMID: 20692834 Free article.

5

Development of triarylsulfonamides as novel anti-inflammatory agents.

Greig IR, Coste E, Ralston SH, van 't Hof RJ. Greig IR, et al. Among authors: ralston sh. Bioorg Med Chem Lett. 2013 Feb 1;23(3):816-20. doi: 10.1016/j.bmcl.2012.11.067. Epub 2012 Nov 29. Bioorg Med Chem Lett. 2013. PMID: 23265887

6

Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.

van't Hof RJ, Ralston SH. van't Hof RJ, et al. Among authors: ralston sh. J Bone Miner Res. 1997 Nov;12(11):1797-804. doi: 10.1359/jbmr.1997.12.11.1797. J Bone Miner Res. 1997. PMID: 9383684 Free article.

7

Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026).

Armour KJ, van 't Hof RJ, Armour KE, Torbergsen AC, Del Soldato P, Ralston SH. Armour KJ, et al. Among authors: ralston sh. Arthritis Rheum. 2001 Sep;44(9):2185-92. doi: 10.1002/1529-0131(200109)44:9<2185::aid-art372>3.0.co;2-3. Arthritis Rheum. 2001. PMID: 11592384 Free article.

8

The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.

Idris AI, Del Soldato P, Ralston SH, van't Hof RJ. Idris AI, et al. Among authors: ralston sh. Bone. 2004 Sep;35(3):636-43. doi: 10.1016/j.bone.2004.03.036. Bone. 2004. PMID: 15336599

9

Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.

Idris AI, Rojas J, Greig IR, Van't Hof RJ, Ralston SH. Idris AI, et al. Among authors: ralston sh. Calcif Tissue Int. 2008 Mar;82(3):191-201. doi: 10.1007/s00223-008-9104-y. Epub 2008 Feb 8. Calcif Tissue Int. 2008. PMID: 18259679

10

Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.

Idris AI, Greig IR, Bassonga-Landao E, Ralston SH, van 't Hof RJ. Idris AI, et al. Among authors: ralston sh. Endocrinology. 2009 Jan;150(1):5-13. doi: 10.1210/en.2008-0998. Epub 2008 Sep 4. Endocrinology. 2009. PMID: 18772231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters